Saturday, July 11, 2026

Drug profile · INN

velmanase alfa

velmanase alfa (LAMZEDE) is a high mannose oligosaccharides hydrolytic enzyme.

EMA: approved Alimentary tract and metabolism (A16) A16AB15
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — velmanase alfa
Class
Alimentary tract and metabolism (A16)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

velmanase alfa (LAMZEDE) is a high mannose oligosaccharides hydrolytic enzyme.

Key facts

INN velmanase alfa
Brand LAMZEDE
Mechanism High mannose oligosaccharides hydrolytic enzyme
Target High mannose oligosaccharides
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AB15

Mechanism of action

High mannose oligosaccharides hydrolytic enzyme

Primary target: High mannose oligosaccharides

Approval history

Authority Status Date
EMA approved

Related & competitor drugs

  1. agalsidase alfa Alimentary tract and metabolism (A16)
  2. alogliptin Alimentary tract and metabolism (A10)
  3. alogliptin benzoate Alimentary tract and metabolism (A10)
  4. aprepitant Alimentary tract and metabolism (A04)
  5. budesonide Alimentary tract and metabolism (A07)
  6. canagliflozin Alimentary tract and metabolism (A10)

Frequently asked questions

What is velmanase alfa?

velmanase alfa (LAMZEDE) is a high mannose oligosaccharides hydrolytic enzyme.

What is the brand name for velmanase alfa?

LAMZEDE is a marketed brand name for velmanase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.